Physician

Kara Della Torre, M.D.

According to 2025 Medicare claims, Kara Torre, M.D. (NPI: 1649491978) practices ophthalmology in the Camden, NJ market, with the plurality of this provider's patient population coming from Gloucester, NJ. This provider's primary affiliated billing organization is BANNETT EYE CENTERS, PA (NPI: 1437208287; TIN: 223549309) and primary practice location at 08096-1795.

Torre's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 773 traditional Medicare patients, billed 20,893 HCPCS/CPT codes, and received $1,037,608 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,467 prescription claims across 396 beneficiaries totaling $278,706 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 26 records totaling $451. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $103,210 to $278,706. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$549K$1.1M2015 Medicare payment: $770,502 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $909,306 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $923,140 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $847,995 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,026,186 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,024,150 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $938,743 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,073,507 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,097,572 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,037,608 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156194,672$770,502
20167075,459$909,306
20177495,500$923,140
20187965,189$847,995
20197895,549$1,026,186
20206214,728$1,024,150
20216924,878$938,743
20227156,710$1,073,507
202376014,850$1,097,572
202477320,893$1,037,608

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$139K$279K2015 Drug cost: $103,210 (USD; Tot_Drug_Cst)2016 Drug cost: $129,220 (USD; Tot_Drug_Cst)2017 Drug cost: $139,325 (USD; Tot_Drug_Cst)2018 Drug cost: $175,738 (USD; Tot_Drug_Cst)2019 Drug cost: $227,783 (USD; Tot_Drug_Cst)2020 Drug cost: $180,420 (USD; Tot_Drug_Cst)2021 Drug cost: $186,115 (USD; Tot_Drug_Cst)2022 Drug cost: $180,339 (USD; Tot_Drug_Cst)2023 Drug cost: $223,171 (USD; Tot_Drug_Cst)2024 Drug cost: $278,706 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015206819$103,210
2016204937$129,220
20172261,051$139,325
20182801,069$175,738
20193021,023$227,783
2020275991$180,420
2021257953$186,115
2022274934$180,339
20233401,134$223,171
20243961,467$278,706

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more146146$116
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more254403$97
92014Established patient complete exam of visual system395402$85
92012Established patient problem focused exam of visual system266439$69
92134Imaging of retina5411,181$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast502,640$57,148
CyclosporineCyclosporine432,970$29,655
CequaCyclosporine231,530$27,629
RestasisCyclosporine231,230$25,374
RocklatanNetarsudil Mesylat/Latanoprost311,560$18,038

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$451Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kara Della Torre, M.D.?

Tedicare shows public-source Medicare data for Kara Della Torre, M.D. (NPI 1649491978), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kara Della Torre, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kara Della Torre, M.D.?

Kara Della Torre, M.D. is linked to BANNETT EYE CENTERS, PA (billing NPI 1437208287) in the available physician profile data.

Does Kara Della Torre, M.D. have Open Payments data?

Kara Della Torre, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.